| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.2 |